H/2 Credit Manager’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.3M Hold
900,000
3.46% 8
2025
Q4
$17M Hold
900,000
3.73% 9
2025
Q3
$16.8M Hold
900,000
4.16% 8
2025
Q2
$16.6M Hold
900,000
4.55% 8
2025
Q1
$15.7M Hold
900,000
4.18% 8
2024
Q4
$15.6M Hold
900,000
3.98% 8
2024
Q3
$16.7M Hold
900,000
4.33% 8
2024
Q2
$13.9M Hold
900,000
3.73% 9
2024
Q1
$13.3M Hold
900,000
3.41% 9
2023
Q4
$12.8M Hold
900,000
3.17% 10
2023
Q3
$12.5M Sell
900,000
-600,000
-40% -$7.68M 3.47% 11
2023
Q2
$17.7M Buy
1,500,000
+800,000
+114% +$9.11M 5.38% 8
2023
Q1
$8.05M Buy
+700,000
New +$8.66M 2.87% 10

Other funds holding SBRA

H/2 Credit Manager's SBRA Position: Q1 2026 in Review

H/2 Credit Manager held its Sabra Healthcare REIT (SBRA) position steady in Q1 2026 at 900,000 shares worth $17.3M. The position accounts for 3.46% of the portfolio, ranked #8.

H/2 Credit Manager first reported a position in SBRA in Q1 2023 and has held it in 13 quarters since. The position peaked at $17.7M in Q2 2023. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • H/2 Credit Manager held 900,000 shares of Sabra Healthcare REIT worth $17.3M as of Q1 2026.
  • H/2 Credit Manager left its Sabra Healthcare REIT share count unchanged in Q1 2026.
  • Sabra Healthcare REIT made up 3.46% of H/2 Credit Manager's portfolio in Q1 2026, its #8 holding.
  • H/2 Credit Manager first reported a position in Sabra Healthcare REIT in Q1 2023 and has held it in 13 quarters since.
  • H/2 Credit Manager's Sabra Healthcare REIT position peaked at $17.7M in Q2 2023.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on H/2 Credit Manager's 13F filing for Q1 2026, filed 15 May 2026.